---
figid: PMC9178120__fonc-12-899272-g002
figtitle: Contribution of the Tumor Microenvironment to Metabolic Changes Triggering
  Resistance of Multiple Myeloma to Proteasome Inhibitors
organisms:
- Homo sapiens
- Mus musculus
- Enterovirus C
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC9178120
filename: fonc-12-899272-g002.jpg
figlink: /pmc/articles/PMC9178120/figure/f2/
number: F2
caption: Contact independent interactions between MM cells and the TME. Cellular crosstalk
  between MM cells and other key players of the TME triggering the release of soluble
  factors (mainly cytokines, chemokines, and growth factors, but also extracellular
  vesicles). Upon binding to their cognate receptors, soluble factors trigger intracellular
  signaling pathways, which promote myeloma growth and survival as well as BM neovascularization,
  bone remodeling and immune evasion. Ang-1, angiopoietin-1; APRIL, a proliferation-inducing
  ligand; BAFF(-R), B-cell activating factor(-receptor); BCMA, B-cell maturation antigen;
  bFGF, basic fibroblast growth factor; BMSC, bone marrow stromal cell; CCR, C-C motif
  chemokine receptor; COX-2, cycloxygenase-2; CSF-1, colony stimulating factor-1;
  CTLA-4, cytotoxic T lymphocyte antigen-4; CXCL, C-X-C motif chemokine ligand; CXCR,
  C-X-C motif chemokine receptor; DC, dendritic cell; DKK1, dickkopf WNT signaling
  pathway inhibitor 1; EV, extracellular vesicle; FGF-2, fibroblast growth factor-2;
  HGF, hepatocyte growth factor; HIF-1α, hypoxia inducible factor-1α; HSC, hematopoietic
  stem cell; ICAM-1, intercellular adhesion molecule 1; iDC, immature dendritic cell;
  IDO, indoleamine 2,3-dioxygenase; IFN-γ, interferon-γ; IGF, insulin-like growth
  factor; IGF-1R, insulin-like growth factor 1 receptor; IL, interleukin; JAK2, janus
  kinase2; LAG3, lymphocyte-activation gene 3; LFA-1, lymphocyte function associated-1;
  MΦ, macrophage; MAPK, mitogen-activated protein kinase; MCP-1, monocyte chemoattractant
  protein-1; MDSC, myeloid-derived suppressor cell; MIP-1α/ß, macrophage inflammatory
  protein 1-α/ß; MM, multiple myeloma; MMP, matrix metalloproteinase; NFκB, nuclear
  factor kappa B; NK, natural killer cell; PAI-1, plasminogen activator inhibitor-1;
  PD-1, programmed cell death protein 1; PD-L1, programmed cell death 1 ligand 1;
  PDGF, platelet-derived growth factor; PTHRP, parathyroid hormone-related peptide;
  RANK(L), receptor activator of NFκB (ligand); ROS, reactive oxygen species; SCF,
  stem cell factor; sFRP2, secreted frizzled related protein 2; (s)SLAMF7, (secreted)
  signaling lymphocytic activation molecule family member 7; STAT, signal transducer
  and activator of transcription; TAM, tumor associated macrophage; TACI, transmembrane
  activator and CAML interactor; TGF-ß, transforming growth factor-ß; TIM-3, T-cell
  immunoglobulin and mucin-domain containing-3; TNF-α, tumor necrosis factors-α; VCAM1,
  vascular cell adhesion molecule 1; VEGF, vascular endothelial growth factor; VLA-4,
  very late antigen-4.
papertitle: Contribution of the Tumor Microenvironment to Metabolic Changes Triggering
  Resistance of Multiple Myeloma to Proteasome Inhibitors.
reftext: Jonas Schwestermann, et al. Front Oncol. 2022;12:899272.
year: '2022'
doi: 10.3389/fonc.2022.899272
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: multiple myeloma | tumor microenvironment | proteasome inhibitors | resistance
  | metabolism
automl_pathway: 0.9184659
figid_alias: PMC9178120__F2
figtype: Figure
redirect_from: /figures/PMC9178120__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9178120__fonc-12-899272-g002.html
  '@type': Dataset
  description: Contact independent interactions between MM cells and the TME. Cellular
    crosstalk between MM cells and other key players of the TME triggering the release
    of soluble factors (mainly cytokines, chemokines, and growth factors, but also
    extracellular vesicles). Upon binding to their cognate receptors, soluble factors
    trigger intracellular signaling pathways, which promote myeloma growth and survival
    as well as BM neovascularization, bone remodeling and immune evasion. Ang-1, angiopoietin-1;
    APRIL, a proliferation-inducing ligand; BAFF(-R), B-cell activating factor(-receptor);
    BCMA, B-cell maturation antigen; bFGF, basic fibroblast growth factor; BMSC, bone
    marrow stromal cell; CCR, C-C motif chemokine receptor; COX-2, cycloxygenase-2;
    CSF-1, colony stimulating factor-1; CTLA-4, cytotoxic T lymphocyte antigen-4;
    CXCL, C-X-C motif chemokine ligand; CXCR, C-X-C motif chemokine receptor; DC,
    dendritic cell; DKK1, dickkopf WNT signaling pathway inhibitor 1; EV, extracellular
    vesicle; FGF-2, fibroblast growth factor-2; HGF, hepatocyte growth factor; HIF-1α,
    hypoxia inducible factor-1α; HSC, hematopoietic stem cell; ICAM-1, intercellular
    adhesion molecule 1; iDC, immature dendritic cell; IDO, indoleamine 2,3-dioxygenase;
    IFN-γ, interferon-γ; IGF, insulin-like growth factor; IGF-1R, insulin-like growth
    factor 1 receptor; IL, interleukin; JAK2, janus kinase2; LAG3, lymphocyte-activation
    gene 3; LFA-1, lymphocyte function associated-1; MΦ, macrophage; MAPK, mitogen-activated
    protein kinase; MCP-1, monocyte chemoattractant protein-1; MDSC, myeloid-derived
    suppressor cell; MIP-1α/ß, macrophage inflammatory protein 1-α/ß; MM, multiple
    myeloma; MMP, matrix metalloproteinase; NFκB, nuclear factor kappa B; NK, natural
    killer cell; PAI-1, plasminogen activator inhibitor-1; PD-1, programmed cell death
    protein 1; PD-L1, programmed cell death 1 ligand 1; PDGF, platelet-derived growth
    factor; PTHRP, parathyroid hormone-related peptide; RANK(L), receptor activator
    of NFκB (ligand); ROS, reactive oxygen species; SCF, stem cell factor; sFRP2,
    secreted frizzled related protein 2; (s)SLAMF7, (secreted) signaling lymphocytic
    activation molecule family member 7; STAT, signal transducer and activator of
    transcription; TAM, tumor associated macrophage; TACI, transmembrane activator
    and CAML interactor; TGF-ß, transforming growth factor-ß; TIM-3, T-cell immunoglobulin
    and mucin-domain containing-3; TNF-α, tumor necrosis factors-α; VCAM1, vascular
    cell adhesion molecule 1; VEGF, vascular endothelial growth factor; VLA-4, very
    late antigen-4.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FUT1
  - CCL2
  - KITLG
  - TAM
  - STIM1
  - TNFSF11
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - CXCL8
  - FGF2
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - PTGS2
  - CSF1
  - TNFRSF11A
  - TNF
  - SERPINE1
  - IL6
  - IL17A
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - HIF1A
  - ANGPT1
  - TM7SF2
  - HGF
  - SOS1
  - LMNA
  - IDO1
  - DKK1
  - SFRP2
  - IL3
  - CCR8
  - CCR5
  - TGFB1
  - TGFB2
  - TGFB3
  - IL10
  - CCR1
  - SLAMF7
  - CIAO2B
  - TNFRSF1A
  - PTHLH
  - IL1B
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - IL6R
  - IGF1R
  - IL7
  - LINC02605
  - IGF1
  - INHBA
  - INHBB
  - ICAM1
  - VCAM1
  - TNFRSF13C
  - TNFRSF13B
  - TNFRSF17
  - CXCR4
  - TNFSF13B
  - TNFSF13
  - ANP32B
  - Mcpt1
  - Ccl2
  - Kitl
  - Ugt2b5
  - Tnfsf11
  - Vegfa
  - Cxcl15
  - Fgf2
  - Ptgs2
  - Csf1
  - Tnfrsf11a
  - Tnf
  - Serpine1
  - Serpine2
  - Il6
  - Il17a
  - Hif1a
  - Angpt1
  - Ang
  - Tm7sf2
  - Mmp2
  - Mmp9
  - Hgf
  - Met
  - Idc
  - Ido1
  - Dkk1
  - Sfrp2
  - Il3
  - Ccr8
  - Ccr5
  - Tgfb1
  - Ltbp1
  - Il10
  - Ccr1
  - Slamf7
  - Tnfrsf1a
  - Pthlh
  - Il1
  - Nfkb1
  - Il6ra
  - Igf1r
  - Il7
  - Icam1
  - Vcam1
  - Tnfrsf13c
  - Tnfrsf13b
  - Tnfrsf17
  - Cxcr4
  - Tnfsf13b
  - Tnfsf13
  - vegfaa
  - cxcl8a
  - fgf2
  - COX2
  - tnfrsf1b
  - tnfb
  - serpine1
  - il6
  - hif1ab
  - angpt1
  - mmp2
  - mmp9
  - ido1
  - dkk1b
  - sfrp2
  - tnfa
  - ccr2
  - il10
  - kita
  - ngfra
  - pthlha
  - stat1b
  - stat4
  - il6r
  - il7
  - igfn1.2
  - vcam1b
  - cxcr4b
  - tnfsf13
---
